Narrow your search
Listing 1 - 10 of 13 << page
of 2
>>
Sort by

Book
MODELISATION DU METABOLISME DE LA THYMIDINE EN VUE DE SON APPLICATION A L'ETUDE DE LA REGENERATION HEPATIQUE
Authors: ---
Year: 1987 Publisher: Louvain-la-Neuve: UCL,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
The one-third partial hepatectomy: a model to study various factors influencing the liver regeneration
Authors: --- ---
Year: 1994 Publisher: Bruxelles: UCL.,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Our study clearly establishes that the one-third partial hepatectomy is of particular interest in the study of the regenerative response, as In contrast to the two-thirds partial hepatectomy, it can easily be amplified by various factors.
In the first part, infusion of Diprivan (Propofol) increases the DNA synthesis in 10% partial hepatectomy from control value 13.2+/-1.8 to 54.5+/-7.7 (P<0.01),in one-third partial hepatectomy from 41.5+/-3.1 to 102.7+/-11.5 (P<0.001), in sham operation from 7.2+/-1.7 to 23.1+/-3.4 (P<0.01) but not after a two-thirds partial hepatectomy. Infusion in Intralipid emulsion alone also increases the DNA synthesis in 10% partial hepatectomy from 13.2+/-1.8 to 24.3+/-2.0 (P<0.01), in one-third partial hepatectomy from 7.2+/-1.7 to 20.4+/-4.2 (P<0.5) but not in two-thirds partial hepatectomy.
In the second part, a stimulatory effect of HGF administration on the DNA synthesis after a one-third partial hepatectomy, is obtained by two injections, immediately and at 12 hours (from control value 41+/-3.1 to 143+/-27.2 (P<0.001), by continuous infusion during 24 hours (to 109+/-20 P<0.01) or by a single injection at the 10th hour (to 105+/-19.5 O<0.01). By contrast, the administration immediately after the one-third partial hepatectomy seems much less efficient (65+/-18.8).
In the third part, the conversion of one-third into a two-third partial hepatectomy obtains a 24-jour response identical to the one after classic two-thirds partial hepatectomy (315+/-24 versus 333+/-18). By contrast, when the conversion is delayed at 14 hours, this response is markedly reduced (50+/-13).
These results suggest that the one-third partial hepatectomy is an interesting model which is more sensitive and it is susceptible to be modified by various factors such a Diprivan, Intralipid. The magnitude of the regenerative response to a one-third partial hepatectomy is easily modified at around the 10th hour by the administration of HGF or by the further reduction of the liver mass.

Hepatotrophic factors
Author:
ISBN: 0444900187 9780444900180 Year: 1978 Publisher: Amsterdam: Elsevier,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Hepatitis and chronic liver disease
Authors: ---
Year: 1996 Publisher: London : W.B. Saunders,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
FGF 15/19, rôle potentiel dans la régénération hépatique : revue de la littérature et expérience pilote
Authors: --- ---
Year: 2014 Publisher: Bruxelles: UCL. Faculté de pharmacie et des sciences biomédicales,

Loading...
Export citation

Choose an application

Bookmark

Abstract

FGF19 (fibroblastes growth factor) and its murine homologue FGF15 are members of the subfamily of FGF19 with endocrine action. FGF15 and 19 have a similar expression pattern and they regulate glucose metabolism and bile acids (BA) in a similar way. FGF15/19 plays a cruciale role in the regulating the bile acid pool. Indeed, its expression is induced in the intestine by the acid receptor FXR (Farnesoid X Receptor). FGF15/19 is then released into the circulation and inhibits the expression of CYp7al (the rate-limiting enzyme in the classical pathway of BA synthesis) in the liver. Iker Uriarte et al. Pinpointed that FGF15 is a critical hormone in modulating the rate of BA during liver regeneration. Therefore, we questioned whether FGF15/19 could have an impact on the proliferation and differentiation of progenitor cells into hepatocytes and cholangiocytes. In order to assess this hypothesis we evaluated the effect of recombinant FGF19 (r FGF19) injections on progenitor cells in a murine model hepatotocixity. We exposed C57BL/6J mice to a choline-deficient, ethionine-supplemented diet (CDE) during 23 days to stimulate expansion of progenitor cells.During the last 11 days mice were injected with PBS or rFGF19.This preliminary experiment showed that: 1) rFGF19 injections are well tolerated, 2) the rFGF19 is active in mice, it is detected in treated mice’s serum (whereas it’s undetectable in control mice) and inhibits effectively the expression of Cyp7al in the liver. By using the localization in the CDE model we did not observe any evident effect produced by rFGF19: LPC seem to have a similar localization in the CDE mice treated with rFGF19 compared to thecontrols. Moreover, both mice groups present a comparable number of LPC. We could continue our study by analyzing the effects in a different mouse model (OPN-iCreERT2; Rosa26RYFP- that allows tracking the fate of progenitor cells, so as to evaluate the impact of FGF19 on the differentiation of progenitor cells in hepatocytes. Le FGF19 (facteur de croissance des fibroblastes – fibroblastes growth factor) ou son homologue murin, FGF15 sont membres de la sous famille du FGF19 à action endocrine. Les ARN messagers (ARNm) de FGF15 et FGF19 sont des profils d’expression similaires et régulent de la même façon le métabolisme du glucose et des acides biliaires. FGF15/ FGF19 joue un rôle important dans la régulation du pool des acides biliaires. En effet, son expression est induite dans l’intestin par le récepteur aux acides biliaires FXR (Farnesoid X Receptor). Il est alors relargué dans la circulation et va inhiber l’expression de CYp7al dans le foie, enzyme de synthèse des acides biliaires. Iker Uriarte et al. ont identifié FGF15 comme une hormone essentielle dans la modulation du taux de BA au cours de la régénération du foie. Nous proposons que le FGF15 pourrait influencer la prolifération et la différenciation des cellules progénitrices en hépatocytes et cholangiocytes. Pour évaluer cette question nous avons évalué l’effet de l’administration de FGF19 recombinant sur les cellules progénitrices dans un modèle murin d’hépatotoxicité. Nous avons exposé des souris C57BL6J à un régime déficient en choline supplémentée en éthionine (CDE), pendant 23 jours pour induire l’expansion des cellules progénitrices. Pendant les 11 derniers jours, les souris ont été injectées avec du rFGF19 humain ou du PBS. Cette expérience préliminaire a permis de montrer que 1) les injections de rFGF19 sont bien tolérées, 2) que le rFGF19 est fonctionnel chez la souris : il est détecté dans le sérum des souris traitées (indétectables dans les souris contrôles) et inhibe bien l’expression de Cyp7al dans le foie. Dans un modèle d’induction des cellules progénitrices, nous n’avons pas observé d’effet évident du rFGF19 : les LPC semblent aussi nombreuses et ont une localisation similaire chez les souris CDE traitées au rFGF19 ou non. On pourrait continuer notre étude en allant à analyser la réponse de modèle des souris différents (OPN-IcreERT2 ; Rosa26RYFP) qui permet de suivre le devenir des cellules progénitrices, et ainsi d’évaluer l’effet de FGF19 sur la différenciation des cellules pro génitrices en hépatocytes.

Liver regeneration and carcinogenesis : molecular and cellular mechanisms
Author:
ISBN: 128103309X 9786611033095 0080535542 0123853559 9780123853554 9780080535548 Year: 1995 Publisher: San Diego : Academic Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Because of its marked capacity to regenerate and the ability of chemical carcinogens and viruses to ready transform hepatocytes, the liver has been used extensively as a model for investigating the molecular mechanisms of cellular proliferation and carcinogenesis. Recently, striking advances have occured in the understanding of hepatocyte growth regulation and the manner in which chemical agents and viruses alter these normal growth regulatory pathways in liver carcinogenesis. This explosion of information has occured in a multitude of research disciplines. This book brings together current fin


Book
Hepatic circulation : physiology and pathophysiology
Author:
ISBN: 1615040099 1615040102 Year: 2010 Publisher: San Rafael, Calif. (1537 Fourth Street, San Rafael, CA 94901 USA) : Morgan & Claypool,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The Hepatic circulation is unique among vascular beds. The most obvious unique features include the dual vascular supply; the mechanism of intrinsic regulation of the hepatic artery (the hepatic arterial buffer response); the fact that portal blood flow, supplying two thirds of liver blood flow, is not controlled directly by the liver; the fact that 20% of the cardiac output rushes through the most vascularized organ in the body, driven by a pressure gradient of only a few millimeters of mercury; the extremely distensible capacitance and venous resistance sites; the unidirectional acinar blood flow that regulates parenchymal cell metabolic specialization; and the high concentration of macrophagic (Kupffer) cells filtering the blood. The liver is the only organ reported to have regional blood flow monitored by the autonomic nervous system. This mechanism, when dysfunctional, accounts for the hepatorenal syndrome and offers a mechanistic therapeutic target to treat this syndrome. The trigger for liver regeneration is dependent on hepatic hemodynamics so that chronic liver blood flow regulates liver cell mass. In severe liver disease, the whole body circulation is reorganized, by forming portacaval shunts, to accommodate the increased intrahepatic venous resistance. These shunts protect the venous drainage of the splanchnic organs but lead to loss of major regulatory roles of the liver. The development of knowledge of the hepatic vasculature is presented from a historical perspective with modern concepts summarized based on the perspective of the author's four decades of devotion to this most marvelous of organs.


Book
Liver regeneration : basic mechanisms, relevant models and clinical applications
Author:
ISBN: 0128004312 0124201288 9780128004319 9780124201286 Year: 2015 Publisher: London, UK ; San Diego, CA ; Waltham, MA : Elsevier,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Liver Regeneration: Basic Mechanisms, Relevant Models and Clinical Applications presents cutting-edge information on liver regeneration research through an integrated, systems-wide perspective. The book addresses discoveries on hepatic progenitor cells, liver regeneration after chemical damage, and liver regeneration as a prime therapy for liver failure and disease. By addressing the urgent need for translating basic research findings into clinically relevant modalities and potential therapeutic applications, the book provides the data needed to improve liver patient management. Hundre


Book
Developments in tissue engineered and regenerative medicine products : a practical approach
Authors: ---
ISBN: 1908818115 190756876X 9781908818119 9781907568763 Year: 2012 Volume: no. 48 Publisher: Cambridge : Woodhead Pub.,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Developments in tissue engineered and regenerative medicine products summarizes recent developments in tissue engineering and regenerative medicine with an emphasis on commercialization and product development. Features of current cell therapy and tissue engineered products which have facilitated successful commercialization are emphasized and roadblocks to successful product development are also highlighted. Preclinical and clinical testing of tissue engineered and regenerative medicine products, regulatory, quality control, manufacturing issues, as well as generating and securing intellectua


Book
Bioengineering Liver Transplantation
Authors: --- ---
ISBN: 3039217453 3039217445 Year: 2019 Publisher: MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

The aim of this Special Issue is to review, understand, and evaluate new and exciting opportunities from the field on regenerative medicine, biomaterials, and stem cell research for the bioengineering of human liver grafts that can be applied for transplantation and personalized treatment of end-stage liver disease.The development of culture conditions for long-term expansion of LGR5+ intestinal stem cells as crypt-villus structures demonstrated the feasibility of deriving complex, organ-like structures in vitro from primary adult tissues, including the liver. Moreover, human pluripotent stem cells (hPSCs) can be applied to generate functionally maturated liver and bile duct epithelial cells.In this Special Issue, we welcome reviews and original papers focussing on hepatic cell sources, including adult hepatic stem cells, organoids, fetal and induced pluripotent stem cells, and primary cells (i.e., hepatocytes, cholangiocytes, and endothelial cells) and how these cells can be applied in tissue engineering strategies to generate implantable and personalized liver grafts. Potential topics include, but are not limited to, the following: liver tissue engineering, liver regeneration, graft repair, liver stem cells and organoids, bio-scaffolds, and 3D printing.We invite you to contribute original research papers, as well as comprehensive reviews, aligned with these themes, to advance and improve the actual state-of-the-art in liver bioengineering and providing new opportunities for the imminent medical problem of organ and tissue shortage for transplantation.

Listing 1 - 10 of 13 << page
of 2
>>
Sort by